Brazil has announced plans to produce a low-cost measles and rubella vaccine for export to developing countries.
By 2017, 30 million doses a year are to be supplied mainly to African but also to Asian and Latin American nations.
The Oswaldo Cruz Foundation, Brazil’s top medical research facility has received a dollar one million grant from the Bill and Melinda Gates Foundation.
The vaccine is expected to be the most affordable on the market and will be the first made for export by Brazil.
Currently, only India produces such vaccines.